Briumvi

Aduhelm Therapy in Modesto

Briumvi

BRIUMVI (ublituximab-xiiy) is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Administration Information

Briumvi is the anti-CD20 therapy that is administered as a twice yearly 1 hour infusion (after 2 initial loading doses)

Number of yearly treatments: 4

150 mg over 4 hours
Day 0
450 mg over 4 hours
Day 0
450 mg over 1 hour
Every Weeks 0

Potential Side Effects

Potential side effects: Most common adverse reactions (greater than/equal to 10%) were infusion reactions such as pyrexia, chills, headache, flu-like illness, tachycardia, nausea, throat irriation, erythema and an anyphylactic reaction. Other common side effects were upper respiratory tract infections.

 

For a full list of potential side effects, please see the Briumvi website.

Helpful Resources

Omegahealthclinics Treatment Tips

Patient Forms

Before you attend your first appointment at Omega Health, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!

Patient Consent Form

Print & Sign

HIPAA Privacy Authorization Form

Print & Sign

Notice of Privacy Practice

Read

Patient Rights and Responsibilities

Read

Appointment Lateness and Cancelation

Read

The Omega Health Clinics Experience

We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.

At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.